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The design of systems affects the likelihood and nature of errors that people might make with them, and the 
ease of error recovery. If developers are to design systems that are less prone to errors propagating, they 
need to consider the users and user contexts. There are many techniques and resources available to support 
developers in this. In this paper we report on an interview study involving professionals from major 
manufacturers of medical devices, to better understand their development practices and the external forces 
that shape those practices. This identified barriers to user-centered design and corresponding opportunities 
for support. Results are divided into four themes. These are: collaborative working practices; understanding 
the user and their situation; providing adequate justification for the adoption of a user-centered approach; 
and the provision of clear guidance and support. Our findings highlight the importance of ensuring that 
techniques are adequately justified, applied at the correct time, aligned with the development lifecycle and 
easy to adopt.  
 
INTRODUCTION 
 
Within healthcare, there is a growing recognition that 
“human error” is not independent of the broader system within 
which individuals act and interact; United Kingdom 
Department of Health (DH, 2001). Under this view, errors are 
not attributed in entirety to the individual involved; rather, 
they are a consequence of a failure of one or several parts of 
the system.  
This approach is reflected in regulatory controls; for 
example, in the European Union (EU), the medical device 
industry is subject to a framework requiring those who market 
a device to be:  
“reducing, as far as possible, the risk of use error due to 
the ergonomic features of the device and the environment 
in which the device is intended to be used.” (EU, 1993) 
In the US, the Food and Drug Administration (FDA) may 
require developers to demonstrate how human factors 
considerations were applied during product development, and 
has recently announced an initiative to improve the safety and 
effectiveness of infusion pumps. This is in light of concerns 
regarding the user interaction such as: 
“confusing or unclear on-screen user instructions, which 
may lead to improper programming of medication doses or 
infusion rates.” (FDA, 2010b) 
More generally, there have been several reported examples 
of infusion devices where the design has compromised use. 
Examples include unintentional rebooting of the pump, key 
bounce or numeric entry errors resulting in over-infusion, and 
pumps that impose a programming sequence that does not 
match the hospital workflow; U.S. Association for the 
Advancement of Medical Instrumentation (AAMI/FDA, 2010; 
FDA, 2010a). The premise of our work is that interventions 
applied during the design process can reduce the likelihood of 
such interaction difficulties arising. 
The aim of the study reported here was to better 
understand how, in practice, developers of interactive medical 
devices such as infusion pumps build a user-centered 
perspective into their development processes, how external 
forces shape those processes, and what tools and resources 
might be useful to them in future.  
Beyond the formal documentation such as the Medical 
Devices Directive, there are informal resources such as the 
Design for Patient Safety guide to electronic infusion devices, 
produced by the UK National Patient Safety Agency (NPSA, 
2010) and human error analysis methods such as the 
Technique for Human Error Assessment (THEA: Pocock, 
Fields, & Harrison, 2001).  
Previous work has asked related questions regarding the 
design and delivery of home use devices (Gupta, 2007). In that 
study, developers suggested that Human Factors Engineering 
(HFE) helped identify issues and problems, but that there was 
a lack of science-based support. Designers reported that they 
placed minimal reliance on usability guidance and tended to 
rely upon experience and user trials. The study reported here 
takes a similar approach, but focuses on the design of devices 
that are typically used in hospital settings. 
 
METHOD 
 
In this work we used grounded theory to explore the issues 
regarding the development of infusion devices. We 
interviewed practitioners involved in development, training or 
marketing in order to build an understanding of current 
techniques and identify opportunities for support. Grounded 
theory is a method designed to support the building of theory 
through qualitative analysis of data. The practicalities and 
suitability of this method are described elsewhere (Furniss, 
Blandford, & Curzon, 2011). We chose the method as it suited 
the diverse and complex setting of the healthcare industry.  
 
Participants  
 
We interviewed a range of professionals who have an 
interest in the interactive properties of infusion devices. Table 
2 describes the background of the participants. 10 participants 
were chosen based upon their industrial experience or 
participation in UK National Health Service (NHS) safety 
initiatives. Where participants held senior positions, they 
maintained awareness of relevant tools and techniques.    
 
Procedure  
 
An approach email was sent to participants inviting them 
to become involved in research aiming to transform the design 
and use of interactive medical devices (www.chi-med.ac.uk). 
Contacts were established in March 2010 and interviews were 
conducted between April 2010 and October 2010.  
We used semi-structured interviews based upon a series of 
core questions (Table 1). Where possible, interviews were 
audio recorded and transcribed for analysis. In cases where 
this was not possible, extensive notes were taken. Nine 
interviews were face to face and two over the phone. One 
participant was interviewed over the phone and face to face in 
order to gain additional data (MDC-01-01 and MDC-01-02). 
Data were transcribed and loaded into ATLAS Ti (Scientific 
Software Development GmbH). Interviews were analyzed in 
sequence. We made the final report available to participants to 
verify that their views were accurately represented. Quotations 
used to illustrate themes are taken from transcripts, and 
consequently from three participants, but the analysis 
underpinning the results is from all 11 datasets.  
 
Analysis and Conceptual Development  
 
The first author conducted a process of open coding. As 
successive transcripts were analyzed, the population of codes 
Figure 1. Identified themes and meta-themes.   
 
Table 1  
Interview Topics: User Centered Design (UCD) Approach   
Topic Description 
T1: Personal 
Background, 
Organizational 
Structure 
Practitioner role and responsibility, 
internal and external relationships 
and dependencies.  
T2: Fit in Landscape  Known stakeholders.  
T3: Example Product  Example product including 
interactive properties.  
T4: Awareness of 
Standards and 
Support 
Awareness, interpretation, utility and 
relevance of design guidelines and 
standards.  
T5: Interface Design 
Methods  
Awareness, interpretation, utility and 
relevance of UCD tools, details of 
development process. 
T6: Interface Design 
Challenges 
Mechanisms to prevent input error, 
interface design drivers / trade offs. 
Fit within development process. 
T7: Interface Design 
Assessment  
Application of user testing, 
evaluative techniques, verification 
and validation. Fit within 
development process. 
T8: Post Marketing 
Activities  
Training, user documentation, 
monitoring of device alerts and 
recalls, opportunities for support, 
constraints and dependencies.  
 
Table 2 
Description of Participants  
Ref Company 
Profile 
Position Recording 
Method 
HCI-
01-01 
NA Director of 
Research Lab, 
Usability 
Consultancy  
Notes 
MDC-
01-01 
Global 
healthcare 
provider 
Patient Safety 
Advocate 
Notes 
MDC-
01-02 
See MDC-
01-01 
See MDC-01-01 Transcript  
MDC-
02-01 
Global 
healthcare 
provider 
Business 
Development 
Manager 
Notes 
MDC-
03-01 
Global 
healthcare 
provider 
Training and 
Marketing 
Professionals  
Notes  
MDC-
04-01 
 
Software 
consultancy 
Team Lead Notes 
 
MDC-
04-02 
Software 
consultancy 
Software 
Development and 
Usability  
Transcript 
MDC-
05-01 
Global 
healthcare 
provider 
Human Factors 
Program 
Manager 
Notes 
MDC-
06-01 
Global 
healthcare 
provider 
Business 
Manager  
Notes 
MDC-
02-02 
Global 
healthcare 
provider 
Vice President 
Marketing 
Notes 
MDC-
07-01 
Local 
healthcare 
provider 
Chief Executive Transcript 
Note. MDC = Medical Device Company, HCI = HCI 
Consultant, MDC-XX-YY: XX = Medical Device 
Company serial, YY = Interview number for company.  
 
 
grew to 132. Codes were abstracted to determine themes and 
meta-themes. 6 themes were identified (Figure 1), namely: 
Collaborative Working Practices; Understanding the User and 
their Situation; Adequate Justification of User Centered 
Design; Clear Guidance and Support; Communication of 
Mandatory Controls and Industry Wide Standardization. The 
majority of codes related to a single theme, in a minority of 
cases a single code related to multiple themes. Themes were 
grouped under two meta-themes, namely Regulation and 
Design and Development (Figure 1). In this paper, we focus 
on the Design and Development themes.  
 
RESULTS 
 
Overall, participants were familiar with a range of HFE 
and UCD techniques and reported that they performed over 
and above the mandatory requirements. One company had 
recently revised the development process to include additional 
usability tests and documentation; in another case, the output 
of user tests and evaluation were stored on a database and 
shared across the company.  
 
Collaborative Working Practices  
 
Several participants reported examples of poor 
communication compromising device design. A usability 
practitioner spoke of isolated team members and geographical 
constraints leading to breakdowns in communication: 
“the designer is completely isolated, he is out in 
[location].” (MDC-04-02) 
Some manufacturers subcontracted to external design 
consultancies and found establishing common processes or 
toolsets could be difficult. When multiple organizations 
worked together, introduction of new processes required 
justification, and organizations had: 
“problems understanding why it should be different and 
why somebody from outside should come and apply new 
process.” (MDC-04-02) 
Usability practitioners highlighted potential conflicts 
relating to working alongside marketing professionals: 
“it is becoming better, but in the beginning I have a feeling 
that the marketing department which is the major contact 
point… usually they were the ones that defined what the 
pumps should look like.” (MDC-04-02) 
Other interviews provided positive examples regarding 
good communication speeding the development timeline: 
“they were very responsive to design change suggestions, 
and were able to come up with prototypes pretty quickly, 
because there wasn’t a huge structure between us and 
them….  …in a large corporation it’s probably multiple 
levels of approval before something gets back to the 
engineers and someone says right, okay, design it.” 
(MDC-07-01) 
In summary, good communication practices and the 
development of a common perspective were seen as essential. 
Difficulties included team members not being co-located or 
organizational structure or excessive bureaucracy slowing 
decision making. Suggested solutions included embedding 
usability practitioners in engineering teams, coordinating the 
timing of development activities and collecting and 
confirming requirements across multiple stakeholders.    
 
Understanding the User and their Situation 
 
All participants were aware of the need to include user 
tests; however, there were reports of relatively uninvolved 
sessions, where participants were restricted to commenting on 
the aesthetic aspects of the device. Participants reported 
difficulties in assessing how many “users” should be involved 
in user tests and maintained that justifying the resource 
required was difficult. Participants emphasized difficulties in 
establishing the level to which the user had been trained:  
“This is real life, you know, there are people who are 
untrained, who were not there at the day of the training or 
who were hired only a couple of days after the training 
and then they receive training by a colleague who may not 
have understood the product fully.” (MDC-04-02) 
Participants also spoke of situations where users have been 
trained on a legacy product type and may experience 
difficulties in transferring to a new product: 
“You know, when new technology comes in they’re 
actually quite intimidated by it and it’s like… it’s new I’ve 
got to retrain and everything else.” (MDC-07-01) 
In summary, participants found it hard to understand how 
user tests could be designed to be indicative of situated use. 
Clarification of best practice and guidance regarding the range 
and type of users and testing techniques was required.    
 
Adequate Justification of User Centered Design  
 
Justification of resource challenged practitioners across a 
range of UCD and HFE techniques. Participants raised a need 
for methods to establish the cost and benefit of techniques: 
“the understanding of the customer when it comes to 
usability methods is why do we need to do that and why 
would it be useful, I have to explain it every time.” (MDC-
04-02) 
There were also concerns that those responsible for 
purchasing or evaluating devices may be too detached from 
the development team or too late in the development process 
to ensure UCD techniques are adopted. Participants reported 
significant penalties for not adopting a UCD approach, 
including potential delays to market, product recalls and 
litigation, as one participant put it: 
“what people don’t realize is that, lets say they can’t 
afford to, the argument should come back, you can't afford 
not to, because of litigation.” (MDC-01-02) 
Companies worked alongside notified bodies (providers of 
advice on regulatory compliance) to help determine the 
appropriate level of documentation and process. A close 
relationship and frequent dialogue with the notified body was 
seen as beneficial. Participants had difficulties in justifying 
guidance that was ambiguous, open ended or conflicting.  
 
Clear Guidance and Support  
 
Given concerns regarding the clarity of support, we asked 
developers about the utility of the various resources. 
Participants stated they needed prohibitively large amounts of 
time to search, assimilate and implement guidance, and 
complained about the relevance and specificity of material: 
“I can only talk about the usability standard.... I think this 
one is not really well done… because it is too general, the 
process as described is so fuzzy. […] I look at MAUDE 
[refers to FDA Manufacturer and User Facility Device 
Experience database] but I can’t get useful information 
concerning the products I am working on.” (MDC-04-02) 
Participants suggested that any developer intending to use 
a systematic approach is faced with a bewildering array of 
documents containing complex interdependencies and lengthy 
annexes, and they reported guidance that was device specific, 
graphical and practical as preferential: 
“For instance such a nice guide like your NHS one here 
[refers to NPSA booklet (NPSA, 2010)] where you just 
show three case studies and also list the process they were 
doing along with the pitfalls, this would be much more 
beneficial than 8 pages of standard and 60 pages of 
annex.” (MDC-04-02) 
Participants also reported a lack of available guidance: 
“there is no guidance when it comes to usability, it is a bit 
like operating in an empty space.” (MDC-04-02) 
 
DISCUSSION 
 
Having identified these four key themes, we now propose 
ways in which these challenges could be addressed through 
changes in development processes, and identify future 
research challenges in this area. 
 
Collaborative Working Practices  
 
Participants highlighted the challenges of poor 
communication and conflicting agendas within and across 
organizations involved in development. Elsewhere in the 
industry, Samaras and Horst (2005) report on the adoption of a 
common development framework such as systems 
engineering, which was found to improve the integration of 
ergonomic and engineering practice. 
Some of our participants took an agile approach to 
development, which poses particular challenges to integrating 
a human factors perspective as it is difficult to keep user-
centered requirements gathering, user testing and product 
development synchronized (Kollmann, Sharp, & Blandford, 
2009). Agile processes need to involve usability practitioners, 
with a good grasp of the technical aspects of development, 
within engineering teams to help developers to avoid falling 
into the trap of designing for themselves. However, to help 
achieve the rapid turn-around that is common in agile 
processes, there is a need for user representations such as 
personas (Cooper, 1999) and scenarios (Carroll, 1995) that 
represent the users and their needs. 
 Within more traditional development processes, personas 
and scenarios have been applied to medical design across a 
number of contexts (Shah, Robinson, & AlShawi, 2009; 
Sutcliffe et al., 2010; Wiklund, 2006). A particular value of 
personas and scenarios is that they have been found to be 
effective mediating representations that support 
communications between those with UCD and technical 
focuses (Blandford, Keith, Butterworth, Fields, & Furniss, 
2007) – an important challenge in medical device design. 
Work is needed to develop and test a comprehensive and 
useful set of personas and scenarios to support development 
teams, and to explore other mediating representations that 
support communication across different cultures within teams.  
 
Understanding the User and their Situation  
 
Practitioners reported difficulties in anticipating the level 
of training or experience possessed by the user. It is unrealistic 
to expect the manufacturer to imagine every possible 
combination of device, user and usage scenario; however, a 
reasonable coverage of likely eventualities is necessary. 
Usability standard IEC 62366:2007 calls for developers to 
collect a user profile that considers age, gender, linguistic and 
cultural background along with the level of education, 
professional competence, potential disabilities and intended 
conditions for use. Consequently, there needs to be a concept 
of the user from the outset (Wiklund, 2006).Well-defined and 
complete user requirements are therefore beneficial, although 
challenges remain relating these to functional requirements. 
(Martin, Norris, Murphy, & Crowe, 2008). 
 
Adequate Justification of User Centered Design  
 
Participants reported that securing the necessary resource 
for UCD was difficult and had to be constantly justified. There 
are methods available to support; however, they often need to 
be adapted for a given domain and set of circumstances. For 
example, cost savings achieved through more usable devices 
leading to reductions in training needs or staff numbers are 
specific to a domain of application and context of use.    
Karat, 1997 states that for every dollar of investment spent 
on ease of use, there is a two to one hundred dollar return on 
investment. Ensuring UCD techniques are applied at the 
correct point in time and matched to the domain of application 
has the potential to maximize the benefit. Recording and 
managing the resource assigned in this area allows 
organizations to compare and contrast across cases.   
As well as cost-justifying UCD, it is important to 
recognize that there are several overarching principles that 
allow organizations to realize the maximum benefit from UCD 
or HFE. These include problem prioritization and severity 
assessment (methods to help assign development resource) 
(Hertzum, 2006), ensuring usability principles are applied 
proactively to architectural design (Bass & John, 2003), 
choosing appropriate methods (Jaspers, 2009) and tailoring the 
methods to the phase of design (Kamper, 2002).  
 
Clear Guidance and Support 
 
Developers were often unaware of guidance or felt it to be 
inappropriate or inadequate. There are opportunities for 
improvement, including identifying and addressing gaps in 
provision, signposting appropriate support, and considering 
suitable ways to present and distribute information. 
Developers stated a preference for concise, graphically 
illustrated and design orientated material such as the 
guidelines produced as part of a multidisciplinary “Design for 
Patient Safety” initiative (NPSA, 2010). The rationale behind 
device developers, ergonomists and design professionals 
producing guidance together is that content will stipulate 
necessary design requirements and be communicated in a way 
that is accessible to a wide audience (Buckle, Clarkson, 
Coleman, Ward, & Anderson, 2006). Future work could 
suggest practical, easily adopted resources that allow 
developers to predict error and integrate appropriate 
mitigations. Approaches could include provision of scenarios 
of use (based upon observational study in hospitals and 
patients homes), checklists of design features, interactive tools 
to analyze proposed systems and examples and novel designs 
that have been proven to reduce error.  
 
Conclusion 
 
Our participants, who represent most of the major 
manufacturers of medical devices, were all aware of the need 
for UCD or HFE techniques; however, they had difficulties in 
implementation. Through this study, we have identified key 
areas where developers need tools, techniques and evidence to 
inform the requirements for new designs and to evaluate the 
degree to which candidate design options are likely to lead to 
safer systems that are less susceptible to human error.   
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